TREM2 and Alzheimer disease: Acute inflammatory conditions, as those mimicked by in vitro studies, could thus reduce TREM2 expression, while the chronic inflammation observed in pathological conditions, such as AD, would results in increased TREM2 expression, possibly in the attempt to augment phagocytosis.